Halozyme
HALO
509 hedge funds and large institutions have $5.86B invested in Halozyme in 2024 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 178 increasing their positions, 178 reducing their positions, and 82 closing their positions.
185% more call options, than puts
Call options by funds: $36.9M | Put options by funds: $12.9M
11% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 82
0% more funds holding
Funds holding: 508 → 509 (+1)
0% more repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 178
2.53% less ownership
Funds ownership: 98.88% → 96.35% (-2.5%)
18% less capital invested
Capital invested by funds: $7.17B → $5.86B (-$1.3B)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$70.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$64.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$38.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$29.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$28.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$90.3M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$74.5M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$72.7M |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$49.4M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$36.4M |
HALO Hedge Fund Activity: Q4 2024 in Review
509 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2024, worth a combined $5.86B — down 18% from $7.17B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new HALO positions and 82 closed out — a net gain of 9 holders — while 178 added to existing stakes and 178 trimmed.
The largest buyer was Bank of America, adding an estimated $70.7M. The largest seller was Artisan Partners, cutting an estimated $90.3M.
- 509 institutional investors held Halozyme (HALO) as of Q4 2024, up from 508 in Q3 2024.
- Funds reported $5.86B of Halozyme stock for Q4 2024, down 18% quarter-over-quarter.
- 91 funds opened new Halozyme positions in Q4 2024 and 82 closed out, a net change of +9 holders.
- The largest Halozyme buyer in Q4 2024 was Bank of America, an estimated $70.7M added.
- The largest Halozyme seller in Q4 2024 was Artisan Partners, an estimated $90.3M sold.
Based on aggregated 13F filings for Q4 2024.